Skip to main content
OpenTrials
Completed

NCT Number: NCT01891617

Exercise Effects on Insulin, Gut Peptides, and Appetite

Determine whether the mid-day suppression of hunger and amplified increase in the release of glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide 1 (GLP-1) following morning exercise is due to increased fat content of the diet per se or a combination of high fat diet after morning exercise. The action of gut peptides, particularly GLP-1, on gastric emptying is likely to be important in mediating its effects on postprandial appetite and glycemia (Nauck et al. 1997). Our hypothesis is that exercise amplifies gut peptide secretion when diet is enriched with fat, and that this stimulus suppresses the hunger sensation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Michigan Clinical Research Unit

Ann Arbor, Michigan, 48109, United States

About this study

Specific aim: Determine whether a change in macronutrient composition from 60% carbohydrate and 25% fat to 30% carbohydrate and 45% fat is responsible by itself for suppression of hunger and increased secretory response of glucose-dependent insulinotropic hormone (GIP) and glucagon-like peptide-1 (GLP-1), or whether these changes depend on preceding exercise. We will measure (a) concentrations of plasma GIP and GLP-1 by chemiluminescent multiplex assay, (b) concentrations of plasma ancetaminophen to assess the gastric emptying rate, (c) concentrations of plasma insulin, and glucagon by radioimmunoassay, and glucose, ketone bodies, and free fatty acids with appropriate spectrophotometric methods, (d) hourly appetite responses with visual analog scale under two conditions: sedentary (SED) and exercise (EX).

Hypothesis: Hunger suppression and secretion of GIP and GLP-1 after the morning meal will be greater with slower gastric emptying rate when a meal consisting of 45% fat and 30% carbohydrate follows three hours after a 2-hour bout of moderate-intensity exercise than in the absence of exercise.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Postmenopausal status
  • Age 50 to 65 years
  • BMI between 20 and 30 kg/m2.
  • Good health status (normotensive, fasting glucose < 100 mg/dl, , hematocrit > 32%, hemoglobin >12 mg/dl)
  • Absence of restricted food intake
  • Absence of endocrine and metabolic disorders requiring medication other than hormonally corrected hypothyroidism
  • Absence of musculoskeletal disabilities that would prevent walking

Exclusion criteria

  • Presence of endocrine and metabolic disease requiring medication, other than hormonally corrected hypothyroidism
  • Presence of musculoskeletal disabilities that would prevent walking
  • Smoking
  • Active dieting
  • Absence of listed inclusion criteria
  • Unwillingness to follow study protocol.

Treatment and study plan

Exercise and diets

Other

Exercise and high-fat diet Exercise and high-carbohydrate diet Sedentary and high-fat diet Sedentary and high-carbohydrate diet

Primary outcomes

  1. Plasma insulin concentration

    Time frame: 36 hours

    Change in plasma insulin to two bouts of exercise followed by a high-carbohydrate or a high fat diet

  2. Plasma glucagon concentration

    Time frame: 36 hours

    Changes in plasma glucagon concentration to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal

  3. Plasma concentration of glucose-dependent insulinotropic peptide (GIP)

    Time frame: 36 hours

    Changes in plasma concentration of glucose-dependent insulinotropic peptide (GIP)to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal

  4. Plasma concentration of free fatty acids

    Time frame: 36 hours

    Changes in plasma concentration of free fatty acidsto two bouts of exercise followed by either a high-carbohydrate or a high-fat meal

  5. Plasma concentration of beta-hydroxybutyrate

    Time frame: 36 hours

    Changes in plasma concentration of beta-hydroxybutyrate to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal

  6. Plasma glucose concentration

    Time frame: 36 hours

    Changes in plasma glucose concentration to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal

  7. daytime hourly appetite ratings

    Time frame: 36 hours

    Changes in daytime hourly appetite ratings to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal

Secondary outcomes

  1. Plasma concentrations of glucagon-like peptide-1 (GLP-1)

    Time frame: 36 hours

    Changes in plasma concentrations of glucagon-like peptide-1 (GLP-1)to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal

  2. Plasma concentrations of peptide tyrosine tyrosine (PYY)

    Time frame: 36 hours

    Changes in plasma concentrations of peptide tyrosine tyrosine (PYY) to two bouts of exercise followed by either a high-carbohydrate or a high-fat meal

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry information

Official study title

The Exercise Effects on Appetite and Gut Peptides While on High-fat Diet

Acronym: XFG

Important dates

Study start
2010
Primary completion
2012
Study completion
2013
First posted
Jul 3, 2013
Registry last updated
Jun 13, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.